Drug-labels.com

Elelyso: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
200 UNIT
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Elelyso

What is Elelyso used for?

  • Elelyso is an enzyme replacement therapy for pediatric and adult patients with Gaucher disease.

How does Elelyso work?

Gaucher disease is a genetic disorder caused by a missing or defective enzyme name glucocerebrosidase. When this enzyme is missing or does not work properly, a substance called glucocerebroside builds up inside cells in the body. The build-up of this substance causes the signs and symptoms found in Gaucher disease.

Signs of the disease are one or more of the following:

  • Spleen or liver enlargement
  • A low number of red blood cells (anaemia)
  • A tendency to bleed easily caused by a low blood platelet count
  • Bone disease

What are the ingredients in Elelyso?

Medicinal ingredients: Taliglucerase alfa

Non-medicinal ingredients: Citric acid anhydrous, Mannitol, Polysorbate 80, Sodium citrate.

Elelyso comes in the following dosage forms:

Elelyso 200 units is presented as a powder for solution for infusion. Elelyso is supplied in a 13.5mL vial.

Do not use Elelyso if:

  • you are allergic to taliglucerase alfa or to any ingredient in the formulation or component of the container.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Elelyso. Talk about any health conditions or problems you may have, including if you:

  • have previously experienced an adverse reaction related to the infusion or allergic reaction with another enzyme replacement therapy for Gaucher disease
  • have allergies to this drug or its ingredients or components of the container; or if you are allergic to carrots
  • are pregnant or plan to become pregnant or are breast-feeding

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

No interaction studies have been performed.

How to take Elelyso:

Usual dose:

Dosage is individualized for each patient. Elelyso is only used under the supervision of a health care professional. If you are tolerating your infusions well in the clinic, your doctor may suggest that the infusion be administered at home by a health care professional.

The initial doses of Elelyso range from 30 units/kg to 60 units/kg of body weight.

Elelyso is given once every two weeks.

Overdose:

There is no experience with overdose of taliglucerase alfa with doses over 78 units/kg.

If you think you, or a person you are caring for, have taken too much Elelyso, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you have missed an Elelyso infusion, please contact your doctor.

What are possible side effects from using Elelyso?

These are not all the possible side effects you may have when taking Elelyso. If you experience any side effects not listed here, tell your healthcare professional.

Like all medicines, Elelyso can cause side effects, although not everybody gets them.

Most side effects are mild to moderate and generally are associated with the infusion however side effects may be serious and may need treatment.

The most serious adverse reactions seen were allergic reactions. If you have an allergic reaction following administration of Elelyso, contact your doctor immediately. If a severe allergic reaction occurs, immediately discontinue Elelyso. If you experience an allergic reaction your doctor or nurse may continue treatment by slowing the infusion rate and/or giving you medicines such as antihistamines, antipyretics or corticosteroids. Pre-treatment with antihistamines and/or corticosteroids may prevent subsequent reactions.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
VERY COMMON
HeadacheX
Abdominal painX
Pain in extremity, Joint painX
FatigueX
VomitingX
Back painX
ItchingX
COMMON
Allergic reactionsX
DizzinessX
FlushingX
Throat irritationX
NauseaX
RednessX
RashX
Bone painX
Infusion related reactionX
Infusion site painX
SwellingX
Weight increaseX

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Unopened vial: store under refrigeration (2°-8°C). Keep the vial in the outer carton in order to protect from light. Do not use after the expiry date printed on the label.

Keep out of reach and sight of children.

If you want more information about Elelyso:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website http://www.pfizer.ca, or by calling 1-800-463-6001.

Last Revised: March 7, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02425637

Revision date stated in the text: March 7, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Elelyso

Rx or OTC
Prescription (Rx)?
DIN 02425637
Schedule(s) PRESCRIPTION; SCHEDULE D
Active ingredient(s) Taliglucerase alfa 200 UNIT
Dosage form(s) Powder For Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A16 Other alimentary tract and metabolism products
      1. A16A Other alimentary tract and metabolism products
        1. A16AB Enzymes for alimentary tract and metabolism
          1. A16AB11 Taliglucerase alfa
Company PFIZER CANADA ULC
Current status Cancelled Post Market
Current status date May 5, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.